Michael Wang, M.D., Ph.D., Chief Strategy Officer, Author at NFCR

Therapeutic Vaccines Showed Long-term Anti-Cancer Effects for Melanoma

When people hear the word “vaccine”, they often think about vaccine’s preventive function that protects people from getting infectious diseases such as flu, hepatitis or Covid-19.  It’s true that traditional vaccines are developed to prevent infectious diseases, but innovative scientists are developing therapeutic vaccines that can treat various non-infectious diseases,…...

Read more

3 Things to Know Before Getting the Covid-19 Vaccine

The nationwide Covid-19 vaccine rollout has vaccinated millions of people, which helps to significantly reduce the number of new cases and protect the people of high risk, including cancer patients, from being infected.  A fast vaccination will push the country entering the stage of herd immunity, namely enough population in…...

Read more

Catching Cancer Cells on Their Way to Spreading

NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...

Read more

3 Important Tips For Immuno-Oncology Drug Treatment

Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are brought into remission by the IO-based immunotherapy. IO drugs work…...

Read more